28/11/2023 09:13

Allkem Ltd (AKE) $8.35

AKE’s merger with Livent is basically complete, which creates an operation with more scale, but it’s the lithium price that will continue to dictate its share price through 2024/5. We like the risk/reward towards AKE around current levels, but we would leave plenty of funds to average in case the established downtrend extends lower

Read more

20/10/2023 09:21

Allkem Ltd (AKE) $11.11

AKE tumbled -5.5% on Thursday as lithium investors/traders flocked for the exits. After flagging a $640mn cost blowout last month, with higher labour and material expenses cited as the major cause, even as the stock approaches major support. The Livent merger is set to be completed by the end of 2023 and the larger entity will likely be more appealing once things are all bedded down, although we prefer other Lithium stocks in the sector.

Read more

26/09/2023 09:02

Allkem Ltd (AKE) $11.62

AKE led the lithium stocks lower on Monday after flagging a $640mn cost blowout across three major projects, one in Canada and two in South America, with higher labour and material expenses cited as the cause. Allkem’s chief executive tried to remain optimistic, stating that “the outlook for lithium, a key ingredient in EV batteries, remains strong.”

Read more

08/09/2023 09:13

Allkem Ltd (AKE) $13.49

AKE has recently become a global mining giant after merging with Livent Corp (LTHM US), from a M&A perspective the horse appears to have bolted here with the future investment thesis dictated by the operations of the combined entity plus of course the underlying lithium price.

Read more

29/08/2023 09:23

Allkem Ltd (AKE) $13.65

AKE reported a strong FY23 result with revenue US$1,208m and NPAT US$525m coming in above consensus. The result included no new updates on major projects or the Livent merger which is still targeting completion this year (CY23). The merge of Allkem and Livent will produce a $15bn global force in lithium that will be traded in New York and on the ASX as CDI’s i.e. in similar fashion to Newcrest and Newmont.

Read more

25/07/2023 09:13

Allkem Ltd (AKE) $15.06

AKE is currently merging with Livent to create a New York-listed $US10.6bn global force and if all goes according to plan it should be complete by Christmas – AKE shareholders get 1-1 in the new company and LTHM receive 2.406 of the new entity – this is a great example in our opinion of the cream floating to the top in this relatively new industry.

Read more

23/05/2023 09:38

Allkem Ltd (AKE) $15.00

AKE rallied over +25% after the attractive deal with Livent that was revealed to the market, the surge was no great surprise to MM but the stock is starting to feel fully priced around/above $16, especially when compared to its peers. The new company (NewCo) will have a market capitalisation of about A$15 billion, similar in size to Pilbara (PLS), and be listed on the NYSE plus CDIs on the ASX.

Read more

12/05/2023 09:14

Allkem (AKE) $14.94 & Livent (LTMN US) $US25.62

Allkem has a good lithium brine project in Argentina which is in a critical delivery and ramp up phase, and on Wednesday (after close) they announced a friendly merger with US listed Livent (LTMN US). The new company (NewCo) will have a market capitalisation of about A$15 billion, similar in size to Pilbara (PLS).

Read more

11/05/2023 16:42

Allkem (AKE) $14.94

AKE +15.72%: announced a merger with US group Livent (LTHM US) to create the world’s 3rd largest lithium producer forcing shares in lithium miners to squeeze higher today. Allkem shareholders, which was born out of a merger between Galaxy and Orocobre, will own 56% of the combined group, however, Livent’s CEO Paul Graves will be tasked with combining the assets.

Read more

29/03/2023 09:29

Allkem Ltd (AKE) v IGO Ltd (IGO)

The combination of the $5bn bid for LTR and short squeeze across the sector sent the lithium sector significantly higher on Tuesday with Allkem (AKE) +13.7% and IGO (IGO) +6.8% two of the standouts. We believe the fundamentals for lithium are strong on a multi-year view although near-term risks remain but prices should stabilise mid-year/Q3 as contracts get renegotiated, provided China/World EV demand remains on track.

Read more